Načítá se...
Emerging treatments for bacillus Calmette–Guérin-unresponsive non-muscle-invasive bladder cancer
Intravesical bacillus Calmette–Guérin (BCG) immunotherapy has been the gold standard adjuvant treatment for intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) after transurethral resection of bladder tumor (TURBT). BCG immunotherapy prevents disease recurrence and progression to...
Uloženo v:
| Vydáno v: | Investig Clin Urol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Korean Urological Association
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8246016/ https://ncbi.nlm.nih.gov/pubmed/34085791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/icu.20200602 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|